XML 51 R38.htm IDEA: XBRL DOCUMENT v3.25.3
Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Disaggregation of Revenue [Line Items]        
Revenues $ 102,239 $ 94,878 $ 294,735 $ 273,701
Net investment income (loss) 632 550 1,639 1,398
Total revenues 102,871 95,428 296,374 275,099
Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 59,548 54,659 167,404 154,036
Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 5,192 5,196 15,803 15,847
Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 33,719 30,925 100,734 91,983
Other        
Disaggregation of Revenue [Line Items]        
Revenues 3,780 4,098 10,794 11,835
Health Care Benefits        
Disaggregation of Revenue [Line Items]        
Revenues 35,431 32,555 105,667 96,577
Net investment income (loss) 513 423 1,307 1,076
Health Services        
Disaggregation of Revenue [Line Items]        
Revenues 42,354 40,794 120,568 115,954
Net investment income (loss) (1) (1) 10 (3)
Pharmacy & Consumer Wellness        
Disaggregation of Revenue [Line Items]        
Revenues 24,441 21,515 68,460 61,127
Net investment income (loss) 0 0 0 0
Corporate/ Other        
Disaggregation of Revenue [Line Items]        
Revenues 13 14 40 43
Net investment income (loss) 120 128 322 325
Operating Segments | Health Care Benefits        
Disaggregation of Revenue [Line Items]        
Net investment income (loss) 513 423 1,307 1,076
Total revenues 35,993 32,996 107,061 97,707
Operating Segments | Health Care Benefits | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Care Benefits | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Care Benefits | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 33,739 30,914 100,731 91,947
Operating Segments | Health Care Benefits | Other        
Disaggregation of Revenue [Line Items]        
Revenues 1,741 1,659 5,023 4,684
Operating Segments | Health Services        
Disaggregation of Revenue [Line Items]        
Net investment income (loss) (1) (1) 10 (3)
Total revenues 49,266 44,129 139,181 126,585
Operating Segments | Health Services | Pharmacy network        
Disaggregation of Revenue [Line Items]        
Total revenues 26,408 24,136 74,187 66,448
Operating Segments | Health Services | Mail & specialty        
Disaggregation of Revenue [Line Items]        
Total revenues 20,392 17,214 58,071 52,127
Operating Segments | Health Services | Other        
Disaggregation of Revenue [Line Items]        
Total revenues 2,467 2,780 6,913 8,013
Operating Segments | Health Services | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 46,800 41,350 132,258 118,575
Operating Segments | Health Services | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Services | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Services | Other        
Disaggregation of Revenue [Line Items]        
Revenues 2,467 2,780 6,913 8,013
Operating Segments | Pharmacy & Consumer Wellness        
Disaggregation of Revenue [Line Items]        
Net investment income (loss) 0 0 0 0
Total revenues 36,214 32,423 101,707 90,986
Operating Segments | Pharmacy & Consumer Wellness | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 30,428 26,666 84,135 73,463
Operating Segments | Pharmacy & Consumer Wellness | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 5,192 5,196 15,803 15,847
Operating Segments | Pharmacy & Consumer Wellness | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Pharmacy & Consumer Wellness | Other        
Disaggregation of Revenue [Line Items]        
Revenues 594 561 1,769 1,676
Corporate/ Other | Corporate/ Other        
Disaggregation of Revenue [Line Items]        
Net investment income (loss) 120 128 322 325
Total revenues 133 142 362 368
Corporate/ Other | Corporate/ Other | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Corporate/ Other | Corporate/ Other | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Corporate/ Other | Corporate/ Other | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 11 11 34 36
Corporate/ Other | Corporate/ Other | Other        
Disaggregation of Revenue [Line Items]        
Revenues 2 3 6 7
Intersegment Eliminations        
Disaggregation of Revenue [Line Items]        
Net investment income (loss) 0 0 0 0
Total revenues (18,735) (14,262) (51,937) (40,547)
Intersegment Eliminations | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues (17,680) (13,357) (48,989) (38,002)
Intersegment Eliminations | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Intersegment Eliminations | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues (31) 0 (31) 0
Intersegment Eliminations | Other        
Disaggregation of Revenue [Line Items]        
Revenues (1,024) (905) (2,917) (2,545)
Intersegment Eliminations | Health Care Benefits        
Disaggregation of Revenue [Line Items]        
Total revenues (49) (18) (87) (54)
Intersegment Eliminations | Health Services        
Disaggregation of Revenue [Line Items]        
Total revenues (6,913) (3,336) (18,603) (10,634)
Intersegment Eliminations | Pharmacy & Consumer Wellness        
Disaggregation of Revenue [Line Items]        
Total revenues $ (11,773) $ (10,908) $ (33,247) $ (29,859)